Carrollton, TX, United States of America

Joseph Ready

USPTO Granted Patents = 35 

 

Average Co-Inventor Count = 4.4

ph-index = 10

Forward Citations = 399(Granted Patents)


Location History:

  • Austin, TX (US) (2017)
  • Carrolton, TX (US) (2017 - 2019)
  • Carrollton, TX (US) (2012 - 2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
35 patents (USPTO):Explore Patents

Title: Joseph Ready: An Innovator Modulating Health Disorders

Introduction:

Joseph Ready, hailing from Carrollton, Texas, is a prominent inventor and researcher in the field of biomedical science. With an impressive portfolio consisting of 33 patents, Ready has contributed significantly to the development of novel compositions and methods to modulate various health disorders. This article will provide an overview of his latest patents, key career highlights, notable collaborations, and shed light on his impactful contributions to the biomedical field.

Latest Patents:

Ready's most recent patents exhibit his expertise in modulating the activity of short-chain dehydrogenase and 15-PGDH (15-hydroxyprostaglandin dehydrogenase) to treat and prevent certain diseases and disorders. His inventions include compositions and methods for modulating 15-PGDH activity, thereby regulating tissue prostaglandin levels to address a range of medical conditions. The 15-PGDH inhibitors, as described in his patents, offer potential therapeutic solutions for treating coronary disorders, congestive heart failure, cardiomyopathy, and diminished cardiac ejection fraction.

Career Highlights:

Joseph Ready has made significant contributions during his tenure at renowned institutions such as the University of Texas System and Case Western Reserve University. His expertise in biomedical research, as reflected by his numerous patents, has played a pivotal role in advancing medical science.

Collaborations:

Ready's collaborative efforts with esteemed individuals in the field further enhance his contributions to the biomedical domain. Noteworthy among his collaborators are Steven L. McKnight and Andrew A. Pieper. These collaborations have likely facilitated the exchange of ideas, fostering innovation, and pushing the boundaries of research.

Conclusion:

Joseph Ready's remarkable career in the field of biomedical science, coupled with his extensive patent portfolio, demonstrates his commitment to advancing medical knowledge and developing effective solutions to combat various diseases and disorders. His innovative approaches and significant contributions to modulating 15-PGDH activity highlight his potential to impact the treatment of coronary disorders and related health conditions. Ready's work serves as an inspiration to fellow researchers and inventors in the pursuit of groundbreaking biomedical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…